Akari Therapeutics PLC (FRA:CLA)
€ 2.08 -0.14 (-6.31%) Market Cap: 25.25 Mil Enterprise Value: 22.26 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 16/100

Akari Therapeutics PLC Business Update Call Transcript

Aug 31, 2020 / 12:30PM GMT
Operator

Welcome to the Akari Therapeutics business update conference call.

(Operator Instructions)

Please be advised that today's conference may be recorded.

(Operator Instructions)

I would now like to hand the conference over to [Peter Razo], Investor Relations representative for Akari Therapeutics. Please go ahead.

Peter Razo
Akari Therapeutics Plc - IR

Thank you, [Sarah]. And good morning, everyone.

Before we begin, I would like to remind everyone that this call will contain forward-looking statements which are subject to risks and uncertainties. Any statements regarding future events, results or expectations are forward-looking statements.

Please note that these forward-looking statements reflect our opinions only as of the date of this call. We undertake no obligation to revise or update these forward-looking statements in light of new information or future events, except as required by law.

Information concerning factors that could cause actual results to differ materially from those contained

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot